Prevalence, contributing factors, and clinical impact of apathy in Parkinson's disease
Authors:
- 20 September 2025
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 191, 382-392
Abstract
No abstract availableKeywords
Funding Information
- Nanjing Medical University (23YJRC21)
- Jiangsu Commission of Health (H2023073)
- Tianjin Municipal Health Commission (TJWJ2024QN062)
This publication has 80 references indexed in Scilit:
- Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal studyInternational Journal of Geriatric Psychiatry, 2024
- Dimensions of apathy in Parkinson's diseaseBrain and Behavior, 2023
- White matter hyperintensities: a marker for apathy in Parkinson’s disease without dementia?Annals of Clinical and Translational Neurology, 2020
- The Prevalence and Determinants of Neuropsychiatric Symptoms in Late‐Stage ParkinsonismMovement Disorders Clinical Practice, 2020
- Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseMovement Disorders, 2011
- The syndromal validity and nosological position of apathy in Parkinson's diseaseMovement Disorders, 2009
- Psychopathological features in patients with Parkinson's disease and related caregivers' burdenInternational Journal of Geriatric Psychiatry, 2009
- How cautious should we be when assessing apathy with the Unified Parkinson's Disease Rating Scale?Movement Disorders, 2009
- Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementiaMovement Disorders, 2008
- Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendationsMovement Disorders, 2008